RAMM Pharma Corp. (CSE:RAMM)

Market Cap	1.79M
Revenue (ttm)	4.34M
Net Income (ttm)	-16.50M
Shares Out	119.39M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	25,218
Open	n/a
Previous Close	0.0200
Day's Range	0.0200 - 0.0200
52-Week Range	0.0200 - 0.0650
Beta	0.22
RSI	36.92
Earnings Date	Feb 28, 2025

About RAMM Pharma

RAMM Pharma Corp., through its subsidiaries, operates pharmaceutical and medical product business in Uruguay, Italy, and Poland. The company engages in the research and development, production, and sale of cannabinoid pharmacology, pharmaceuticals, cosmetics, and nutraceutical products, as well as formulation of cannabis-based pharmaceuticals and other products. It also engages in the resale of medical supplies products; and sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: RAMM

Financial Performance

In 2024, RAMM Pharma's revenue was 4.34 million, a decrease of -14.28% compared to the previous year's 5.07 million. Losses were -16.50 million, 113.7% more than in 2023.